Drugs in preclinical and early-stage clinical development for pancreatic cancer

By Asuthkar Swapna   Rao Jasti S   Gondi Christopher S  

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 2, 2012-02 ,pp. : 143-152

Informa Healthcare

Access to resources Recommend Favorite

Preclinical drug development for childhood cancer

By Moreno Lucas   Chesler Louis   Hargrave Darren   Eccles Suzanne A   Pearson Andrew DJ  

Expert Opinion on Drug Discovery, Vol. 6, Iss. 1, 2011-01 ,pp. : 49-64

Informa Healthcare

Access to resources Recommend Favorite

The cancer stem cell paradigm: a new understanding of tumor development and treatment

By Ebben Johnathan D   Treisman Daniel M   Zorniak Michael   Kutty Raman G   Clark Paul A   Kuo John S  

Expert Opinion on Therapeutic Targets, Vol. 14, Iss. 6, 2010-06 ,pp. : 621-632

Informa Healthcare

Access to resources Recommend Favorite

Preclinical development of TLR ligands as drugs for the treatment of chronic viral infections

By Zhang Xiaoyong   Kraft Anke   Broering Ruth   Schlaak Joerg F   Dittmer Ulf   Lu Mengji  

Expert Opinion on Drug Discovery, Vol. 7, Iss. 7, 2012-07 ,pp. : 597-611

Informa Healthcare

Access to resources Recommend Favorite

Preclinical Development of Low Toxicity Drugs: Focus on Zanamivir, an Anti-Influenza Drug

By Dines G.D.  

Drug Safety, Vol. 19, Iss. 3, 1998-09 ,pp. : 233-241

Adis International

Access to resources Recommend Favorite